Click ingredient brand name for product website.
| Code | Product Name | CAS Number | Purity/Assay |
|---|---|---|---|
| 1207 | L-Homoserine | 672-15-1 | 99% |
| D-Homoserine | 6027-21-0 | 99% | |
| (S)-2-Amino-?-butyrolactone hydrochloride | 2185-03-7 | 98% | |
| (R)-2-Amino-?-butyrolactone hydrochloride | 104347-13-9 | 98% | |
| (S)-3-Aminotetrahydrofuran hydrochloride | 204512-95-8 | 98% | |
| (R)-3-Aminotetrahydrofuran hydrochloride | 1072015-52-1 | 98% | |
| (S)-2-Amino-4-bromobutyric acid hydrochloride | 15159-65-6 | 98% | |
| (R)-2-Amino-4-bromobutyric acid hydrochloride | 177472-34-3 | 98% | |
| 4,6-Dimethylpyrimidinone | 108-79-2 | 98% | |
| Cotinine | 486-56-6 | 97% | |
| Dehydroepiandrosterone acetate (DHEA Acetate) | 853-23-6 | 98% | |
| 0545 | Eflornithine Hydrochloride (1) | 68278-23-9 | 98% |
| Pyridostigmine bromide | 101-26-8 | 99% | |
| Pyridoxamine dihydrochloride | 524-36-7 | 97% | |
| Salacinol | 200399-47-9 | 98% | |
| Thalidomide | 50-35-1 | 98% |
Patents
1. Black Cumin Seed SCF Extract (Nigellin® )
- US 10,881, 623: Compositions for the management of hyperglycemia and related conditions
- US 10,945,969: Compositions containing thymohydroquinone and their method of preparation
2. Boswellia Extract PS (Boswellin® )
- EA023717: Use of a composition for down-regulating/inhibiting PGE2
- AU2011200854; CA2732915; I-434696; MX328842: Composition for down-regulating pro-inflammatory markers
3. Boswellia Polysaccharides (Polybos® / Polysal® )
- US 10,716,823: Adaptogenic compositions and applications thereof
4. Cirpusins®
- US 10,172,903; US 9,782,450; US 9,387,193; AU2015394033; AU2013292593; CA2883176; EA025578; EP3291805; EP3108935; EP2744571; HK1232483; IDP000062703; JP6759243; JP6135761; KR10-1600212; KR10-1717889; NZ622927; PID201708495; RU2691404; SG11201707106U: Composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof
- PH1-2015-500349: Scirpusin A and scirpusin B and anti-obesity potential thereof
5. Coleus Forskohlii Extract (ForsLean® )
- US 10,085,963; AU2015351423; EP3194575; HK1238675; IDP000071226; JP6472453; KR10-2169620; NZ720422: Process and compositions for achieving mammalian energy balance
- NZ552997: Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives
6. Curcuma Longa Extract WS ( uC3 Clear® )
- CA2976689; NZ734491; ZA2017/06503: Method to solubilize curcuminoids in water
7. Garcinia Extract with Garcinol (GarCitrin® )
- US 7,063,861; AU773081; EP1254209; JP4205943; NZ518116: Bioavailable composition of natural and synthetic HCA
8. Garcinia Indica Extract (Livinol™ )
- AU2011352073 ; CA2851663; EP2658374; JP5980228; NZ609878; RU2585245: Hepatoprotectant activity of garcinol
9. LivLonga®
- US 10,653,643: Liver protectant compositions and therapeutic applications
10. Oroxylum Indicum Extract (Sabroxy® )
- US 10,407,401: Process for synthesis of oroxylin A
- US 10, 555, 982; CA3043168; JP6851476; NZ753943: Composition containing oroxylin A and method of extraction thereof
- US 10, 894, 029; JP6796217: Neuroprotective compositions and their use
- EP1986670: Intestinal alpha-glucosidase inhibitors and a process for the isolation and use thereof
- US 7, 855, 200: Method for treatment of gastric ulcers and ulcers induced by aspirin
- US 10, 959, 980: Bioactive molecules from Oroxylum indicum and their therapeutic applications
11. Pterocarpus Extract WS (pTeroSol® )
- IN194292: A process for extraction of antidiabetic formulation mainly containing flavonoid glycosides
- IN192163: A process for isolation of novel compound 2,6-dihydroxy-2-(p-hydroxybenzyl)-3(2H)-benzofuranone-7-C-ß-Dglucopyranoside from Pterocarpus marsupium
12. Selenium Enriched Garlic Powder(SelenoForce® )
- US 7,014,874: Compositions and methods containing Allium sativumLinn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation
- AU2006321973; EP1968620; NZ568233: Compositions containing Allium sativumLinn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation
13. Sugarcane Peel Extract (Policosanol)
- IN229695: A process for obtaining high purity fatty alcohols
14. Terminalia Arjuna Extract – Arjunoglucoside
- US 10,479,749: Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna
15. Tetrahydrocurcuminoids ODN (Curcumin C3 Reduct® )
- EP1328263: Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells
16. LactoSpore® + Turmeric Starch (Starmeric™ )
- US 10,323,227: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
17. Calebin A (CurCousin™ )
- US 8,933,121; US 9,328,330; AU2012366253; AU2014203122; CA2857543; JP6374716; KR10-1702702; NZ614076; NZ 715053; RU2543334; SG192695; ZA2013/05918; ZL201280012577.3: Anti-obesity potential of calebin A. US 9,610,273; US 9,668,999; AU2014202312; CA2850999; CA2963383; EA027148; EP2937084; HK1210590; I-622384; JP6263707; KR10-1647549; NZ624269; MY-170067-A; PH1-2014-000244: Method for the treatment of hypercholesterolemia
- IDP000064827: Calebin A and its effect on hypercholesterolemia
- US 9,220,703; AU2014201769; CA2935898;EP2893926; JP6142446; KR10-1685263; KR10-1685333; MY-175867-A; NZ622909; PH1-2016-501138; SG11201605336Y: Composition and method for the protection of articular cartilage
- EA027614: Use of calebin A to protect mammalian articular cartilage from pathological damage
- US 9,365,486; AU2014203764; CA2858126; EA027726; EP2963007; HK1217689; JP6490927; KR10-1629561; NZ627247: Synthesis of calebin A and its biologically active analogs
- HK1210028: Calebin A for articular cartilage
- EP3085370: Calebin A for inducing lipolysis
- US 9,737,502; CA2893321; IDP000067993; JP6336943; KR10-1763474; MY-182000-A; PH1-2015-000188; RU2643297; SG10201503805X: Calebin A for hepatic steatosis
- US 9,539,232; CA2941050; RU2653103: Calebin A for osteoporosis
- EP2663185; HK1190874: Calebin A for use in the treatment of inflammation and obesity
- EP3085370: Calebin A for inducing lipolysis
18. Oxyresvenox® / Resvenox®
- US 7,253,324: Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers
19. Eflornithine Hydrochloride
- US 6,998,502; US 7,345,196: Convenient process of manufacture for difluoromethylornithine and related compounds
20. DigeZyme®
- AU2016428484; JP6857240; ZA2019/02715: Enzyme composition for therapeutic management of muscle soreness
- ZA2019/07676: Enzyme composition for maintenance of metabolic health
21. LactoSpore®
- US 10,668,115: Stable probiotic compositions containing Bacillus coagulans MTCC 5856 and method of detection thereof
- US 10,609,935: Beverage compositions containing Bacillus coagulans MTCC 5856
- US 9,579,352: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans
- US 10,166,261; AU2016413572; CA3023818; ZL2019/00501: Bacillus coagulans MTCC 5856 for the management of major depressive disorder
- US 10,260,112; CA2999517; EP3356545; MY-185340-A: Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856
- EA037312; EP3240553; JP6629875; KR10-2157043;MY-182658-A; ZL 201680008035.7: Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856
- US 10,806,760: Compositions and methods for reducing flatulence
- US 10,293,008; AU2015308650; EA034017; EP3185877;HK1233174; IDP000066793; JP6630723; KR10-2089566;MX376004; MY-174855-A; SG11201700006U;ZL201580042813.X: Process for enhancing the viable counts of lactic acid bacteria and useful composition thereof
- US 10,792,295; JP6839329: Composition for management of Helicobacter pylori infection
- RU2745755: Anti-pollution compositions containing Bacillus coagulans
22. LactoCran®
- US 9,717,766: Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
23. PeptiSeLect®
- US 8,193,156: Dipeptides incorporating selenoamino acids with enhanced bioavailability- synthesis, pharmaceutical and cosmeceutical applications thereof.
24. MethySelene®)
- US 6,794,537: Manufacturing processes for Se-methyl-L-selenocysteine
- US 6,982,273: Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use
25. PeptiSeLect®
- US 8,003,614: Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof.
26. Metabolicgard®
- US 10,477,886; US 10,258,073: Functional nutritional blend for thermo-metabolic performance
27. WithanAlpha™
- US 10,864,242: Aphrodisiac composition and management of male sexual dysfunction.
28. ZeaLutein®
- US 6,689,400: Process of obtaining compositions of stable lutein and lutein derivatives